FDA approves NephroGenex’s IND application for clinical study of intravenous Pyridorin to treat acute kidney injury
Acute kidney injury (AKI) is a serious medical condition characterized by an abrupt loss of kidney function. AKI is estimated to affect up to 18 percent of hospital